Synergistic interaction between atovaquone and retinol in Plasmodium falciparum in vitro

Wiener Klinische Wochenschrift

Volumn 119, Issue SUPPL. 3, 2007, Pages 45-52

  Exner, Bettina ^a   Wernsdorfer, Gunther ^b   Sirichaisinthop, Jeeraphat ^c   Rojanawatsirivet, Chaiporn ^c   Kollaritsch, Herwig ^a   Wernsdorfer, Walther H ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MAHIDOL UNIVERSITY   (Thailand)

^c MINISTRY OF PUBLIC HEALTH   (Thailand)

Author keywords

Atovaquone; In vitro; Plasmodium falciparum; Retinol; Synergism

Indexed keywords

ATOVAQUONE; RETINOL; ARTESUNATE; ATOVAQUONE PLUS PROGUANIL; FOLIC ACID ANTAGONIST; MEFLOQUINE; ANTIMALARIAL AGENT;

ADULT; AGED; ANTIMALARIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM ISOLATE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IN VITRO STUDY; MALE; MULTIDRUG RESISTANCE; PLASMODIUM FALCIPARUM; SCHIZONT; THAILAND; WORLD HEALTH ORGANIZATION; CHILD; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG POTENTIATION; HUMAN CELL; MALARIA; STRUCTURE ACTIVITY RELATION; ANIMAL; BLOOD; DOSE RESPONSE; DRUG COMBINATION; DRUG EFFECT; LD 50; MALARIA FALCIPARUM; PARASITOLOGY; PHYSIOLOGY; SURVIVAL RATE; TREATMENT OUTCOME;

ANIMALS; ANTIMALARIALS; ATOVAQUONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HUMANS; LETHAL DOSE 50; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; SURVIVAL RATE; TREATMENT OUTCOME; VITAMIN A;

EID: 36049031460     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-007-0868-2     Document Type: Article

References (28)

1. rd millennium. Wien Klin Wochenschr 115 [Suppl 3]: 2-9
2. Thapar MM, Gupta S, Spindler C, Wernsdorfer WH, Björkman A (2003) Pharmacodynamic interactions among atovaquone, proguanil and cycloguanil against Plasmodium falciparum in vitro. Trans R Soc Trop Med Hyg 97: 331-337
3. Kuhn S, Gill MJ, Kain KC (2005) Emergence of atovaquone-proguanil resistance during treatment of Plasmodium falciparum malaria acquired by a non-immune north American traveler to west Africa. Am J Trop Med Hyg 72: 407-409
4. Wichmann O, Muehlen M, Gruss H, Mockenhaupt FP, Surrorp N, Jelinek T (2004) Malarone treatment failure not associated with previously described mutations in the cytochrome b gene. Malar J 3: 14
5. David KP, Alifrangis M, Salanti A, Vestergaard LS, Ronn A, Bygbjerg IB (2003) Atovaquone/proguanil resistance in Africa: a case report. Scand J Infect Dis 35: 897-898
6. Stephensen CB (2001) Vitamin A, infection and immune function. Ann Rev Nutr 21: 167-192
7. Nussenblatt V, Mukasa G, Metzger A, Ndeezi G, Eisinger W, Semba RD (2002) Relationship between carotenoids and anaemia during acute uncomplicated Plasmodium falciparum malaria in children. J Health Popul Nutr 20: 205-214
8. Metzger A, Mikasa G, Shankar AH, Melikiam G, Semba RD (2001) Antioxidant status and acute malaria in children in Kampala, Uganda. Am J Trop Med Hyg 65: 115-119
9. Hautvast JL, Tolboom JJ, West EC, Kafwembe EM, Sauerwein RW, van Staveren WA (1998) Malaria is associated with reduced serum retinol levels in rural Zambian children. Int J Vitam Nutr Res 68: 384-388
10. Das BS, Thurnham DI, Das DB (1996) Plasma alphatocopherol, retinol and carotenoids in children with falciparum malaria. Am J Clin Nutr 64: 94-100
11. Davis TM, Binh TQ, Danh PT, Dyer JR, St John A, Garcia-Webb P, et al (1994) Serum vitamin A and E concentrations in acute falciparum malaria: modulators or markers of severity? Clin Sci (Lond) 87: 505-511
12. Thurnham DI, Singkamani R (1991) The acute phase response and vitamin A status in malaria. Trans R Soc Trop Med Hyg 85: 194-199
13. Varandas L, Julien M, Gomes A, Rodrigues O, van Lerberghe W, Malveiro F, et al (2001) A randomised, double-blind, placebo-controlled clinical trial of vitamin A in severe malaria in hospitalised Mozambican children. Ann Trop Paediatr 21: 211-222
14. Shankar AH, Genton B, Semba RD, Baisor M, Paino J, Tamja S, et al (1999) Effect of vitamin A supplementation on morbidity due to Plasmodium falciparum in young children in Papua New Guinea: a randomised trial. Lancet 354: 203-209
15. Cox SE, Staalsoe T, Arthur P, Bulmer JN, Tagbor H, Hviid L, et al (2005) Maternal vitamin A supplementation and immunity to malaria in pregnancy in Ghanaian primigravids. Trop Med Int Health 10: 1286-1297
16. Cusick SE, Tielsch JM, Ramsan M, Japw JK, Sazawal S, Black RE, et al (2005) Short-term effects of vitamin A and antimalarial treatment on erythropoiesis in severely anemic Zanzibari preschool children. Am J Clin Nutr 82: 406-412
17. Villamor E, Fawzi WW (2005) Effects of vitamin A supplementation on immune responses and correlation with clinical outcomes. Clin Microbiol Rev 18: 446-466
18. Hamzah J, Batty KT, Davis WA, Mori TA, Ching SY, Croft KD (2007) Retinol supplementation in murine Plasmodium berghei malaria: effects on tissue levels, parasitaemia and lipid peroxidation. Int J Parasitol 37: 525-537
19. Samba DC, Basco LK, Bleiberg-Daniel F, Lemmonier D, Le Bras J (1992) Absence of effect of retinol on the in vitro development of Plasmodium falciparum. Int J Vitam Nutr Res 62: 99-100
20. Davis TM, Skinner-Adams TS, Beilby J (1998) In vitro growth inhibition of Plasmodium falciparum by retinol at concentrations present in normal human serum. Acta Trop 69: 111-119
21. Thriemer K, Wernsdorfer G, Rojanawatsirivet C, Kolla-ritsch H, Sirichaisinthop J, Wernsdorfer WH (2005) In vitro activity of artemisinin alone and in combination with retinol against Plasmodium falciparum. Wien Klin Wochenschr 117 [Suppl 4]: 45-48
22. Samal D, Rojanawatsirivet C, Wernsdorfer G, Kollaritsch H, Sirichaisinthop J, Wernsdorfer WH (2005) Synergism of desbutyl-benflumetol and retinol against Plasmodium falciparum in vitro. Wien Klin Wochenschr 117 [Suppl 4]: 39-44
23. World Health Organization (1990) In vitro micro-test (Mark II) for the assessment of the response of Plasmodium falciparum to chloroquine, mefloquine, quinine, sulfadoxine/pyrimethamine and amodiaquine. WHO document MAP 87.2 (Corr. 1 incl.) Revision 1, June 1990
24. Wernsdorfer WH, Wernsdorfer MG (1995) The evaluation of in vitro tests for the assessment of drug response in Plasmodium falciparum. Mitteilungen Oesterr Gesellsch Tropenmed Parasitol 17: 221-228
25. Litchfield JT Jr, Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharm Exp Ther 96: 99-113
26. Berenbaum MC (1978) A method for testing for synergy with any number of agents. J Infect Diseases 137: 122-130
27. Lütgendorf C, Rojanawatsirivet C, Wernsdorfer G, Sirichai-sinthop J, Kollaritsch H, Wernsdorfer WH (2006) Pharmacodynamic interaction between atovaquone and other antimalarial compounds against Plasmodium falciparum in vitro. Wien Klin Wochenschr 118 [Suppl 3]: 70-76
28. Na-Bangchang K, Manyando C, Ruengweerayut R, Kioy D, Mulenga M, Miller GB et al (2005) The pharmacokinetics and pharmacodynamics of atovaquone and proguanil for the treatment of uncomplicated falciparum malaria in third-trimester pregnant women. Eur J Clin Pharmacol 61: 573-582